Vimarsana
Biggest News Aggregation in the World

Page 10 - Device Designations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Device Designations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Device Designations Today - Breaking & Trending Today

CytoSorbents Reports New Cardiac Surgery Data with CytoSorb at the European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting - Vimarsana News

CytoSorbents Reports New Cardiac Surgery Data with CytoSorb at the European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

Published: October 12, 2022

PRINCETON, N.J., Oct. 12, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions i...

Source: businessinsider.com
Related Topics:
United StatesWest GermanMatthias Thielmann EssenGeorg KlinikMatthias ThielmannEfthymios DeliargyrisEric KimDaniel WendtKathleen BlochGerman Heart CentersMaterial CommandUniversity DuisburgDepartment Of NephrologyEuropean Association For CardioUniversity Of NurembergGerman Heart Vascular CenterEuropean UnionUs ArmyCytosorbents CorporationNational HeartBlood InstituteUniversity Of EssenUs Department Of HealthNational Institutes Of HealthHuman Services
CytoSorbents Announces Pending Retirement of Chief Financial Officer Kathleen P. Bloch - Vimarsana News

CytoSorbents Announces Pending Retirement of Chief Financial Officer Kathleen P. Bloch

Published: October 7, 2022

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Source: prnewswire.com
Related Topics:
United StatesEric KimKathleenp BlochPhillip ChanKathleen BlochSarbanes OxleyUs Department Of HealthHuman ServicesMaterial CommandNational Institutes Of HealthUs AirMagazine Public CompanyEuropean UnionUs ArmyBlood InstituteCytosorbents CorporationNational HeartSorbents CorporationChief Financial OfficerChief Executive OfficerAmong KathyPublic CompanyChapter PresidentMercer ChapterNew Jersey Society
CytoSorbents to Present at the Dawson James Securities 2022 Small Cap Growth Conference - Vimarsana News

CytoSorbents to Present at the Dawson James Securities 2022 Small Cap Growth Conference

Published: October 4, 2022

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Source: prnewswire.com
Related Topics:
United StatesEric KimDawson JamesPhillip ChanKathleen BlochUs Department Of HealthHuman ServicesMaterial CommandNational Institutes Of HealthUs AirEuropean UnionUs ArmyBlood InstituteCytosorbents CorporationNational HeartSorbents CorporationChief Executive OfficerDawson James SecuritiesCap Growth ConferenceDawson James Securities Conference Webcast LinkInvestor RelationsUse AuthorizationDevice DesignationsTimely Antithrombotic Removal TicagrelorNational Institutes
CytoSorbents Achieves ISO 13485 Certification of Princeton Manufacturing Facility in New Jersey - Vimarsana News

CytoSorbents Achieves ISO 13485 Certification of Princeton Manufacturing Facility in New Jersey

Published: September 27, 2022

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Source: prnewswire.com
Related Topics:
United StatesNew JerseyAstra ZenecaEric KimVincent CapponiAmy VogelUs Department Of HealthHuman ServicesMaterial CommandNational Institutes Of HealthUs AirEuropean UnionUs ArmyBlood InstituteCytosorbents CorporationNational HeartSorbents CorporationChief Operating OfficerDevice DesignationsTimely Antithrombotic RemovalSafety Monitoring BoardUse AuthorizationTimely Antithrombotic Removal TicagrelorNational InstitutesOperations Command
The U.S. Department of Defense Awards CytoSorbents an Approximately $2.0M Contract to Support HemoDefend-BGA™ Development for Life-saving Universal Plasma - Vimarsana News

The U.S. Department of Defense Awards CytoSorbents an Approximately $2.0M Contract to Support HemoDefend-BGA™ Development for Life-saving Universal Plasma

Published: September 9, 2022

PRINCETON, N.J., Sept. 9, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions i...

Source: businessinsider.com
Related Topics:
United StatesMaryann GrudaEric KimAmy VogelCytosorbent HemodefendVincent CapponiDepartment Of DefenseMaterial CommandUs Department Of Defense DoReady Blood Group AntibodyUs Army Medical Research Acquisition ActivityDevelopment ProgramCasualty Care Research ProgramEuropean UnionUs ArmyDefense Medical ResearchBlood InstituteCytosorbents CorporationNational HeartUs Department Of HealthHuman ServicesCasualty Care ResearchNational Institutes Of HealthResearch ProgramsWorld Health Organization